MedeAIR was founded in 2014 by clinicians, scientists and operators who had spent careers inside critical care, surgery, research and national health systems — and who had concluded that the future of healthcare would have to be built, not bought. A decade later, MedeAIR's work spans national health strategy, patented diagnostics, virtual care platforms, and the world's first patient-owned medical digital twin ecosystem.
We work on the healthcare systems of the next decade, not the last. Our 2014 RFDS strategy proposed virtual critical care networks years before they became standard. Our 2017 Quantum Consult™ patent pre-dates today's agentic intake bots. Our 2019 Akkure platform deployed patient-owned medical digital twins before 'digital twin' entered the healthcare lexicon.
Healthcare cannot be transformed one app at a time. MedeAIR designs across seven layers — patient, clinical, workflow, intelligence, infrastructure, research and commercialisation — and treats their integration as the actual product.
We advise organisations because we build and operate the systems we recommend. Every framework MedeAIR publishes has been pressure-tested inside a real venture, patent or national strategic review.
Where commercial gene sequencing and ancestry businesses extract patient data without true consent, MedeAIR's platforms invert the relationship. Patients own their digital twin, control access via blockchain-permissioned smart contracts, and decide which researchers or sponsors can use their data.
National strategic reviews, future-of-care strategy, and translation of emerging technology into operating models for health systems.
Patient-owned genomic digital twins, blockchain-permissioned data, and AI-powered virtual clinical trials.
Patented multimodal consultation engines, computer-vision diagnostics, identity-verified home testing and remote critical-care support.
Design of intelligent care environments integrating diagnostics, AI agents, robotics and immersive collaboration.
Founding, patenting and scaling healthcare ventures — Akkure Genomics, Docnostics / HomeGenie, Quantum Consult™.
Bridging academic research, clinical trials, regulatory pathways and commercial deployment.